Baird lowers Stericycle stock target due to leverage concerns



Friday – Baird revised its outlook on waste management company Stericycle (NASDAQ: ) stock, lowering its price target to $55 from $62 while maintaining a neutral rating.

The company noted that concerns about the company's leverage may have impacted the stock's recent performance. Stericycle management's hints of higher leverage, combined with a tighter margin of error on financial covenants and higher days receivables outstanding (DSO), could add to investor jitters.

Amid these concerns, Stericycle's management announced the launch of a new subscription-based service offering called SID. The development is seen as a positive move with potential benefits for the company.

Despite these changes, Baird has chosen to maintain a neutral position on Stericycle stock in the early stages of the ERP rollout. The company acknowledges that Stericycle presents an attractive long-term improvement opportunity, but prefers to remain cautious until more substantial progress is observed.

Investment Professional Insights

As Stericycle (NASDAQ: SRCL ) launches new SID services and moves through its post-ERP deployment period, investors are paying close attention to the company's financials and market performance. According to real-time data from InvestingPro, Stericycle has a market capitalization of approximately $4.3 billion. Despite a challenging revenue growth outlook, with a change of -3.12% in the trailing 12 months to the first quarter of 2024, the company's gross margin remains strong at 37.79%.

InvestingPro Tips suggests that Stericycle's net profit is expected to grow this year, which could signal a turnaround for the company, which has been unprofitable over the past 12 months. Additionally, the relative strength index (RSI) suggests the stock may be in oversold territory, providing investors with a potential entry point. Analysts predict the company will be profitable this year, a key factor that could influence the stock's direction. It's worth noting, however, that Stericycle currently doesn't pay a dividend to shareholders, which may be a consideration for income-focused investors.

3rd party advertising. Not an offer or recommendation by Investing.com.See disclosures here or
Remove ads
.

For those looking to delve deeper into the Stericycle landscape, InvestingPro offers a wealth of additional advice.Use coupon code PRONEWS24readers can receive an additional 10% discount by subscribing to Pro and Pro+ every year or every two years, thereby obtaining more expert analysis and data to inform investment decisions.

This article was generated with the support of artificial intelligence and reviewed by an editor. For more information, please see our terms and conditions.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *